Metformin, a widely used medication for managing type 2 diabetes, might also offer promising benefits for lung cancer patients, particularly those who are overweight or obese. According to new ...

However, metformin did not protect Black patients against squamous cell carcinoma specifically. “This study strengthens the evidence supporting metformin's potential as a protective agent ...

People taking metformin had a significantly lower risk of basal cell cancer and a significantly lower risk of squamous cell cancer, results show. "This study strengthens the evidence supporting ...

Metformin is now the most widely prescribed pill for type 2 diabetes, researchers said in background notes. Previous studies have suggested that metformin might lower a person’s risk of skin cancer.

Participants with metabolic syndrome who received 1,700 mg metformin daily with or without a Mediterranean diet intervention ...

Additionally, blueberries have been found to benefit people with metabolic syndrome, a condition that increases the risk of ...

patients with type 2 diabetes taking a GLP-1 drug appeared to have a slightly higher risk for kidney cancer than those taking metformin. In addition, GLP-1 studies in animals have indicated that ...